Methode Electronics with ticker code (MEI) now have 2 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 48 and 48 with a mean TP of 48. Now with the previous closing price of 45.6 this would imply there is a potential upside of 5.3%. The 50 day moving average now sits at 41.9 and the 200 day MA is 36.85. The company has a market cap of $1,751m. Visit the company website at: http://www.methode.com
Methode Electronics designs, manufactures, and markets component and subsystem devices worldwide. It operates through four segments: Automotive, Industrial, Interface, and Medical. The Automotive segment supplies electronic and electro-mechanical devices, and related products to automobile original equipment manufacturers directly or through their tiered suppliers. Its products include integrated center consoles, hidden switches, ergonomic switches, transmission lead-frames, and LED-based lighting and sensors, which incorporate magneto-elastic sensing and other technologies that monitor the operation or status of a component or system. The Industrial segment manufactures external lighting solutions; industrial safety radio remote controls; braided flexible cables; current-carrying laminated busbars and devices; custom power-product assemblies, such as PowerRail solution; high-current low-voltage flexible power cabling systems; and powder-coated busbars that are used in various markets and applications comprising aerospace, commercial vehicles, computers, industrial, power conversion, military, telecommunications, and transportation. The Interface segment provides various copper and fiber-optic interface, and interface solutions for the appliance, commercial food service, construction, consumer, material handling, point-of-sale, and telecommunications markets. Its solutions comprise copper transceivers and solid-state field-effect consumer touch panels. The Medical segment offers Dabir Surfaces, a surface support technology aimed at pressure injury prevention for use by patients who are immobilized or otherwise at risk for pressure injuries, including patients undergoing long-duration surgical procedures. The company was founded in 1946 and is headquartered in Chicago, Illinois.